See more : Zhejiang Oceanking Development Co., Ltd. (603213.SS) Income Statement Analysis – Financial Results
Complete financial analysis of Vita Life Sciences Limited (VLS.AX) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vita Life Sciences Limited, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Valuence Merger Corp. I (VMCAW) Income Statement Analysis – Financial Results
- Xinhua News Media Holdings Limited (0309.HK) Income Statement Analysis – Financial Results
- SEGMEN KARDESLER GIDA (SEGMN.IS) Income Statement Analysis – Financial Results
- MegaWatt Lithium and Battery Metals Corp. (WALRF) Income Statement Analysis – Financial Results
- Henderson Land Development Company Limited (0012.HK) Income Statement Analysis – Financial Results
Vita Life Sciences Limited (VLS.AX)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://vitalifesciences.com
About Vita Life Sciences Limited
Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; pregnancy and breastfeeding; men, women, and children's health; antioxidant; and bones and joints. The company markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 74.16M | 66.89M | 57.10M | 46.48M | 42.45M | 41.15M | 37.74M | 37.86M | 38.58M | 36.58M | 35.41M | 30.19M | 24.27M | 20.19M | 17.02M | 14.38M | 11.87M |
| Cost of Revenue | 31.56M | 27.15M | 22.29M | 17.21M | 14.56M | 13.51M | 12.12M | 11.70M | 11.43M | 10.54M | 11.37M | 10.67M | 8.55M | 7.86M | 6.75M | 5.79M | 5.06M |
| Gross Profit | 42.60M | 39.74M | 34.81M | 29.27M | 27.90M | 27.64M | 25.62M | 26.16M | 27.15M | 26.04M | 24.05M | 19.52M | 15.72M | 12.33M | 10.26M | 8.58M | 6.81M |
| Gross Profit Ratio | 57.45% | 59.41% | 60.96% | 62.98% | 65.71% | 67.17% | 67.88% | 69.10% | 70.38% | 71.19% | 67.90% | 64.65% | 64.77% | 61.08% | 60.32% | 59.71% | 57.38% |
| Research & Development | 17.00K | 4.00K | 9.00K | 8.00K | 72.00K | 15.00K | 14.00K | 20.00K | 16.00K | 14.00K | 15.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 18.71M | 16.69M | 14.65M | 14.01M | 14.67M | 13.48M | 11.77M | 11.86M | 12.89M | 11.92M | 11.88M | 10.51M | 9.14M | 7.47M | 5.82M | 5.05M | 4.42M |
| Selling & Marketing | 11.37M | 10.42M | 7.57M | 6.16M | 7.38M | 6.74M | 6.09M | 6.15M | 6.43M | 5.62M | 5.08M | 4.85M | 3.88M | 2.91M | 2.57M | 2.38M | 1.75M |
| SG&A | 30.39M | 27.10M | 22.22M | 20.18M | 22.04M | 20.21M | 17.87M | 18.00M | 19.32M | 17.54M | 16.95M | 15.36M | 13.02M | 10.38M | 8.39M | 7.43M | 6.17M |
| Other Expenses | 0.00 | 1.92M | 1.59M | 1.55M | 1.75M | -1.78M | 1.00K | 242.00K | 37.00K | 171.00K | -16.00K | 81.00K | 21.94K | 6.00M | 162.26K | 1.04M | 504.33K |
| Operating Expenses | 30.39M | 29.02M | 23.80M | 21.73M | 23.79M | 21.57M | 20.92M | 20.71M | 21.08M | 19.33M | 18.49M | 16.73M | 14.23M | 13.44M | 10.45M | 8.97M | 7.23M |
| Cost & Expenses | 61.95M | 56.17M | 46.09M | 38.94M | 38.35M | 35.08M | 33.04M | 32.41M | 32.51M | 29.86M | 29.85M | 27.40M | 22.78M | 21.30M | 17.20M | 14.76M | 12.29M |
| Interest Income | 558.00K | 131.00K | 141.00K | 192.00K | 131.00K | 108.00K | 113.00K | 100.00K | 161.00K | 174.00K | 125.00K | 113.00K | 78.18K | 10.50K | 14.00K | 24.96K | 55.27K |
| Interest Expense | 135.00K | 34.00K | 104.00K | 165.00K | 146.00K | 129.00K | 135.00K | 165.00K | 254.00K | 131.00K | 120.00K | 137.00K | 157.71K | 204.81K | 175.01K | 126.10K | 353.19K |
| Depreciation & Amortization | 512.00K | 599.00K | 409.00K | 553.00K | 604.00K | 403.00K | 337.00K | 266.00K | 114.00K | 118.00K | 113.00K | 94.00K | 93.31K | 117.61K | 147.27K | 161.92K | 134.15K |
| EBITDA | 13.10M | 11.37M | 11.71M | 8.88M | 5.15M | 4.84M | 5.15M | 6.06M | 6.37M | 7.18M | 5.65M | 3.00M | 1.66M | 4.98M | -11.02K | 779.72K | 429.76K |
| EBITDA Ratio | 17.66% | 17.00% | 20.52% | 19.10% | 12.20% | 11.74% | 13.64% | 16.04% | 16.52% | 19.62% | 16.28% | 10.22% | 6.90% | 24.73% | -0.05% | 4.53% | 2.08% |
| Operating Income | 12.22M | 10.77M | 11.31M | 8.32M | 4.57M | 4.43M | 4.81M | 5.81M | 6.26M | 7.06M | 5.65M | 2.99M | 1.58M | 4.87M | -155.12K | 489.45K | 112.28K |
| Operating Income Ratio | 16.47% | 16.11% | 19.80% | 17.91% | 10.77% | 10.76% | 12.75% | 15.33% | 16.22% | 19.30% | 15.96% | 9.91% | 6.51% | 24.14% | -0.91% | 3.40% | 0.95% |
| Total Other Income/Expenses | 236.00K | -299.00K | -62.00K | 27.00K | 41.00K | -1.75M | -20.00K | -168.00K | -73.00K | -134.00K | -43.00K | -162.00K | -84.81K | 5.68M | -66.75K | 711.51K | 396.91K |
| Income Before Tax | 12.45M | 10.74M | 11.20M | 8.16M | 4.43M | 4.33M | 4.68M | 5.64M | 6.00M | 6.93M | 5.52M | 2.84M | 1.40M | 4.63M | -333.30K | 305.87K | -323.87K |
| Income Before Tax Ratio | 16.79% | 16.05% | 19.62% | 17.55% | 10.43% | 10.52% | 12.39% | 14.89% | 15.56% | 18.93% | 15.58% | 9.41% | 5.78% | 22.91% | -1.96% | 2.13% | -2.73% |
| Income Tax Expense | 3.37M | 3.40M | 2.95M | 2.30M | 1.33M | 1.90M | 1.82M | 2.30M | 1.65M | -359.00K | 770.00K | 525.00K | 190.32K | 166.73K | -5.11K | -47.61K | -119.61K |
| Net Income | 9.08M | 7.08M | 8.29M | 6.09M | 3.14M | 2.44M | 2.86M | 3.34M | 4.39M | 7.28M | 4.75M | 2.37M | 1.21M | 4.46M | -328.19K | 353.48K | -253.39K |
| Net Income Ratio | 12.24% | 10.59% | 14.52% | 13.11% | 7.39% | 5.93% | 7.59% | 8.83% | 11.38% | 19.90% | 13.41% | 7.84% | 5.00% | 22.09% | -1.93% | 2.46% | -2.13% |
| EPS | 0.17 | 0.13 | 0.16 | 0.12 | 0.06 | 0.04 | 0.05 | 0.06 | 0.08 | 0.13 | 0.09 | 0.04 | 0.02 | 0.08 | -0.01 | 0.01 | -0.01 |
| EPS Diluted | 0.17 | 0.13 | 0.16 | 0.12 | 0.06 | 0.04 | 0.05 | 0.06 | 0.08 | 0.13 | 0.08 | 0.04 | 0.02 | 0.08 | -0.01 | 0.01 | -0.01 |
| Weighted Avg Shares Out | 53.67M | 52.97M | 52.64M | 52.61M | 54.76M | 54.91M | 55.01M | 55.20M | 55.64M | 56.07M | 55.67M | 54.41M | 57.16M | 54.27M | 50.87M | 48.20M | 26.34M |
| Weighted Avg Shares Out (Dil) | 54.69M | 53.99M | 53.12M | 52.61M | 54.76M | 54.91M | 55.01M | 56.85M | 57.10M | 56.07M | 56.39M | 57.17M | 57.16M | 54.27M | 50.87M | 48.20M | 26.34M |
Source: https://incomestatements.info
Category: Stock Reports